Invasive Fungal InfectionsIFSNCT06346951
Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)
An observational study of Invasive Fungal Infections, run by Sichuan Provincial People's Hospital.
Trial summary
The goal of this survey is to learn about the current status of the diagnosis and treatment of invasive fungal infections among intensive care physicians in Sichuan Province (IFS). Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Invasive Fungal Infections
- How many people
- 300 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2024to 30 Sep 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Intensive care physicians in medical institutions at all levels in Sichuan Province. Anticipated total of 20 centers will participate in the study, with a total of 300 physicians to be included in the survey.
Who may be able to join
- Intensive care physicians in medical institutions at all levels in Sichuan Province
Who cannot join
- Exclude non-Sichuan physicians.
- Excluding physicians who are not engaged in intensive care unit.
About this study
The goal of this survey is to learn about the current status of the diagnosis and treatment of invasive fungal infections among intensive care physicians in Sichuan Province (IFS). Its primary focus lies on answering the following questions: ①awareness and proficiency in diagnosis and treatment; ②the use of antifungal medications; ③the application of microbiological identification and diagnostic methods. We aim to analyze the problems and deficiencies that existed among intensive care physicians in order to provide a basis for the development of targeted training and intervention measures.
- Conditions
- Invasive Fungal Infections
- Medical subject headings
- Invasive Fungal Infections
What is being measured
The primary outcome is the main question the study is designed to answer.
The survey on the hospital's diagnostic and treatment standards and infrastructure for invasive fungal infections
①To investigate the basic knowledge and skill mastery of invasive fungi diagnosis and treatment by intensive care physicians in Sichuan province, including information on pathogenesis, clinical manifestations, diagnosis, and treatment.
② To investigate the concerns and selection tendency of intensive care physicians in Sichuan province in choosing antifungal drugs in practice, including information on treatment types, drug choice, dosage, and treatment course.
Measured: From enrollment to the end of survey at 16 weeks
The survey on the awareness of an invasive fungal infection among intensive care physicians
① To assess the application of pathogenetic detection and diagnostic methods of invasive fungal infections by intensive care physicians in Sichuan Province, including the technical level of fungal smear and culture, PCR detection, histopathological examination, and NGS.
②To analyse the problems and deficiencies in the diagnosis and treatment of invasive fungal infections among invasive care physicians in Sichuan Province, and to provide a reference basis for the development of targeted training and intervention measures.
Measured: From enrollment to the end of survey at 16 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Apr 2024
- Study start1 Jun 2024 (estimated)
- Primary completion30 Sep 2024 (estimated)
- Study completion30 Sep 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Invasive Fungal InfectionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sichuan Provincial People's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lingai Pan, Sichuan Provincial People's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06346951
- Sponsor's protocol ID
- LPan
- Acronym
- IFS
- Status last verified
- Apr 2024
- First submitted
- 7 Mar 2024
- Last updated
- 4 Apr 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)
- ClinicalTrials.gov ID
- NCT06346951
- Acronym / sponsor ID
- IFS / LPan
- Conditions
- Invasive Fungal Infections
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Sichuan Provincial People's HospitalUniversity, hospital or other
- Study start
- 1 Jun 2024 (estimated)
- Primary completion
- 30 Sep 2024 (estimated)
- Study completion
- 30 Sep 2024 (estimated)
- First posted
- 4 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this survey is to learn about the current status of the diagnosis and treatment of invasive fungal infections among intensive care physicians in Sichuan Province (IFS). Its primary focus lies on answering the following questions: ①awareness and proficiency in diagnosis and treatment; ②the use of antifungal medications; ③the application of microbiological identification and diagnostic methods. We aim to analyze the problems and deficiencies that existed among intensive care physicians in order to provide a basis for the development of targeted training and intervention measures.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Intensive care physicians in medical institutions at all levels in Sichuan Province. Anticipated total of 20 centers will participate in the study, with a total of 300 physicians to be included in the survey.
Key inclusion criteria (1 listed)
- Intensive care physicians in medical institutions at all levels in Sichuan Province
Key exclusion criteria (2 listed)
- Exclude non-Sichuan physicians.
- Excluding physicians who are not engaged in intensive care unit.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
The survey on the hospital's diagnostic and treatment standards and infrastructure for invasive fungal infections
Time frame: From enrollment to the end of survey at 16 weeks
①To investigate the basic knowledge and skill mastery of invasive fungi diagnosis and treatment by intensive care physicians in Sichuan province, including information on pathogenesis, clinical manifestations, diagnosis, and treatment. ② To investigate the concerns and selection tendency of intensive care physicians in Sichuan province in choosing antifungal drugs in practice, including information on treatment types, drug choice, dosage, and treatment course.
The survey on the awareness of an invasive fungal infection among intensive care physicians
Time frame: From enrollment to the end of survey at 16 weeks
① To assess the application of pathogenetic detection and diagnostic methods of invasive fungal infections by intensive care physicians in Sichuan Province, including the technical level of fungal smear and culture, PCR detection, histopathological examination, and NGS. ②To analyse the problems and deficiencies in the diagnosis and treatment of invasive fungal infections among invasive care physicians in Sichuan Province, and to provide a reference basis for the development of targeted training and intervention measures.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Invasive Fungal Infections
RecruitingObservational study
Natural History of Individuals With Immune System Problems That Lead to Fungal Infections
Chronic Mucocutaneous Candidiasis, Invasive Aspergillosis
RecruitingObservational study
Middle East Study of Infections in Patients With Hematological Malignancies
Hematological Malignancy, Hematopoetic Stem Cell Transplantation
Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children and Adults
Invasive Candidiasis
RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Invasive Mold Infections
RecruitingObservational study
National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
Pneumococcal Infections, Pneumococcal Conjugate Vaccine
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Invasive Fungal Infections, run by Sichuan Provincial People's Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 4 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The survey on the hospital's diagnostic and treatment standards and infrastructure for invasive fungal infections (time frame: From enrollment to the end of survey at 16 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2024.